FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004287928> ?p ?o ?g. }

• W2004287928 endingPage "73" @default.
• W2004287928 startingPage "66" @default.
• W2004287928 abstract "Most acute ischemic stroke patients arrive after the 3-hour time window for recombinant tissue plasminogen activator (rtPA) administration. The Desmoteplase In Acute Ischemic Stroke trial (DIAS) was a dose-finding randomized trial designed to evaluate the safety and efficacy of intravenous desmoteplase, a highly fibrin-specific and nonneurotoxic thrombolytic agent, administered within 3 to 9 hours of ischemic stroke onset in patients with perfusion/diffusion mismatch on MRI.DIAS was a placebo-controlled, double-blind, randomized, dose-finding phase II trial. Patients with National Institute of Health Stroke Scale (NIHSS) scores of 4 to 20 and MRI evidence of perfusion/diffusion mismatch were eligible. Of 104 patients, the first 47 (referred to as Part 1) were randomized to fixed doses of desmoteplase (25 mg, 37.5 mg, or 50 mg) or placebo. Because of an excessive rate of symptomatic intracranial hemorrhage (sICH), lower weight-adjusted doses escalating through 62.5 microg/kg, 90 microg/kg, and 125 microg/kg were subsequently investigated in 57 patients (referred to as Part 2). The safety endpoint was the rate of sICH. Efficacy endpoints were the rate of reperfusion on MRI after 4 to 8 hours and clinical outcome as assessed by NIHSS, modified Rankin scale, and Barthel Index at 90 days.Part 1 was terminated prematurely because of high rates of sICH with desmoteplase (26.7%). In Part 2, the sICH rate was 2.2%. No sICH occurred with placebo in either part. Reperfusion rates up to 71.4% (P=0.0012) were observed with desmoteplase (125 microg/kg) compared with 19.2% with placebo. Favorable 90-day clinical outcome was found in 22.2% of placebo-treated patients and between 13.3% (62.5 microg/kg; P=0.757) and 60.0% (125 microg/kg; P=0.0090) of desmoteplase-treated patients. Early reperfusion correlated favorably with clinical outcome (P=0.0028). Favorable outcome occurred in 52.5% of patients experiencing reperfusion versus 24.6% of patients without reperfusion.Intravenous desmoteplase administered 3 to 9 hours after acute ischemic stroke in patients selected with perfusion/diffusion mismatch is associated with a higher rate of reperfusion and better clinical outcome compared with placebo. The sICH rate with desmoteplase was low, using doses up to 125 microg/kg." @default.
• W2004287928 created "2016-06-24" @default.
• W2004287928 creator A5003407929 @default.
• W2004287928 creator A5009588075 @default.
• W2004287928 creator A5010432169 @default.
• W2004287928 creator A5023366874 @default.
• W2004287928 creator A5042671764 @default.
• W2004287928 creator A5066797336 @default.
• W2004287928 creator A5067086470 @default.
• W2004287928 creator A5069989341 @default.
• W2004287928 creator A5074780950 @default.
• W2004287928 creator A5079574532 @default.
• W2004287928 creator A5083697264 @default.
• W2004287928 creator A5089535804 @default.
• W2004287928 date "2005-01-01" @default.
• W2004287928 modified "2023-10-17" @default.
• W2004287928 title "The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)" @default.
• W2004287928 cites W1968324224 @default.
• W2004287928 cites W2049156764 @default.
• W2004287928 cites W205495280 @default.
• W2004287928 cites W2071984852 @default.
• W2004287928 cites W2095873074 @default.
• W2004287928 cites W2098032054 @default.
• W2004287928 cites W2164077601 @default.
• W2004287928 cites W2292308933 @default.
• W2004287928 cites W4292339830 @default.
• W2004287928 doi "https://doi.org/10.1161/01.str.0000149938.08731.2c" @default.
• W2004287928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15569863" @default.
• W2004287928 hasPublicationYear "2005" @default.
• W2004287928 type Work @default.
• W2004287928 sameAs 2004287928 @default.
• W2004287928 citedByCount "975" @default.
• W2004287928 countsByYear W20042879282012 @default.
• W2004287928 countsByYear W20042879282013 @default.
• W2004287928 countsByYear W20042879282014 @default.
• W2004287928 countsByYear W20042879282015 @default.
• W2004287928 countsByYear W20042879282016 @default.
• W2004287928 countsByYear W20042879282017 @default.
• W2004287928 countsByYear W20042879282018 @default.
• W2004287928 countsByYear W20042879282019 @default.
• W2004287928 countsByYear W20042879282020 @default.
• W2004287928 countsByYear W20042879282021 @default.
• W2004287928 countsByYear W20042879282022 @default.
• W2004287928 countsByYear W20042879282023 @default.
• W2004287928 crossrefType "journal-article" @default.
• W2004287928 hasAuthorship W2004287928A5003407929 @default.
• W2004287928 hasAuthorship W2004287928A5009588075 @default.
• W2004287928 hasAuthorship W2004287928A5010432169 @default.
• W2004287928 hasAuthorship W2004287928A5023366874 @default.
• W2004287928 hasAuthorship W2004287928A5042671764 @default.
• W2004287928 hasAuthorship W2004287928A5066797336 @default.
• W2004287928 hasAuthorship W2004287928A5067086470 @default.
• W2004287928 hasAuthorship W2004287928A5069989341 @default.
• W2004287928 hasAuthorship W2004287928A5074780950 @default.
• W2004287928 hasAuthorship W2004287928A5079574532 @default.
• W2004287928 hasAuthorship W2004287928A5083697264 @default.
• W2004287928 hasAuthorship W2004287928A5089535804 @default.
• W2004287928 hasBestOaLocation W20042879281 @default.
• W2004287928 hasConcept C126322002 @default.
• W2004287928 hasConcept C127413603 @default.
• W2004287928 hasConcept C141071460 @default.
• W2004287928 hasConcept C142724271 @default.
• W2004287928 hasConcept C146957229 @default.
• W2004287928 hasConcept C168563851 @default.
• W2004287928 hasConcept C203092338 @default.
• W2004287928 hasConcept C204787440 @default.
• W2004287928 hasConcept C27081682 @default.
• W2004287928 hasConcept C2776572282 @default.
• W2004287928 hasConcept C2779581417 @default.
• W2004287928 hasConcept C2780645631 @default.
• W2004287928 hasConcept C2780931571 @default.
• W2004287928 hasConcept C3020199598 @default.
• W2004287928 hasConcept C42219234 @default.
• W2004287928 hasConcept C500558357 @default.
• W2004287928 hasConcept C541997718 @default.
• W2004287928 hasConcept C71924100 @default.
• W2004287928 hasConcept C78519656 @default.
• W2004287928 hasConceptScore W2004287928C126322002 @default.
• W2004287928 hasConceptScore W2004287928C127413603 @default.
• W2004287928 hasConceptScore W2004287928C141071460 @default.
• W2004287928 hasConceptScore W2004287928C142724271 @default.
• W2004287928 hasConceptScore W2004287928C146957229 @default.
• W2004287928 hasConceptScore W2004287928C168563851 @default.
• W2004287928 hasConceptScore W2004287928C203092338 @default.
• W2004287928 hasConceptScore W2004287928C204787440 @default.
• W2004287928 hasConceptScore W2004287928C27081682 @default.
• W2004287928 hasConceptScore W2004287928C2776572282 @default.
• W2004287928 hasConceptScore W2004287928C2779581417 @default.
• W2004287928 hasConceptScore W2004287928C2780645631 @default.
• W2004287928 hasConceptScore W2004287928C2780931571 @default.
• W2004287928 hasConceptScore W2004287928C3020199598 @default.
• W2004287928 hasConceptScore W2004287928C42219234 @default.
• W2004287928 hasConceptScore W2004287928C500558357 @default.
• W2004287928 hasConceptScore W2004287928C541997718 @default.
• W2004287928 hasConceptScore W2004287928C71924100 @default.
• W2004287928 hasConceptScore W2004287928C78519656 @default.
• W2004287928 hasIssue "1" @default.
• W2004287928 hasLocation W20042879281 @default.

• next